TMO - Thermo Fisher Scientific Inc.
269.55 0.00 (0.00%)
After hours: 6:44PM EDT
| Previous Close | 261.56 |
| Open | 261.00 |
| Bid | 261.00 x 800 |
| Ask | 274.70 x 900 |
| Day's Range | 260.66 - 270.46 |
| 52 Week Range | 202.83 - 282.98 |
| Volume | 2,015,485 |
| Avg. Volume | 1,565,762 |
| Market Cap | 107.552B |
| Beta (3Y Monthly) | 1.30 |
| PE Ratio (TTM) | 37.23 |
| EPS (TTM) | 7.24 |
| Earnings Date | Jul 23, 2019 - Jul 29, 2019 |
| Forward Dividend & Yield | 0.76 (0.28%) |
| Ex-Dividend Date | 2019-03-14 |
| 1y Target Est | 290.73 |
- Thomson Reuters StreetEvents•11 hours ago
Edited Transcript of TMO earnings conference call or presentation 24-Apr-19 12:30pm GMT
Q1 2019 Thermo Fisher Scientific Inc Earnings Call
- Zacks•14 hours ago
Zacks.com featured expert Kevin Matras highlights: Foot Locker, Thermo Fisher Scientific, SS&C Technologies, Columbia Sportswear and Comcast
Zacks.com featured expert Kevin Matras highlights: Foot Locker, Thermo Fisher Scientific, SS&C Technologies, Columbia Sportswear and Comcast
- Investor's Business Daily•yesterday
Medtech Stock Skids On Its 'Off-Color Performance' Following FDA Jabs
Boston Scientific stock slipped Wednesday after its first-quarter sales and earnings lagged expectations. But fellow medical technology company Thermo Fisher topped estimates in its report.
- Motley Fool•yesterday
Thermo Fisher Scientific Inc (TMO) Q1 2019 Earnings Call Transcript
TMO earnings call for the period ending March 30, 2019.
- Zacks•yesterday
Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View
Thermo Fisher (TMO) reports strong Laboratory Products and Services performance, flaunting robust global demand.
- Zacks•2 days ago
5 Top-Ranked Cheap Dividend Growth Stocks
While there are several dividend stocks that could provide capital appreciation, honing in on stocks with a history of dividend growth leads to a healthy portfolio with a greater scope of capital appreciation.
- Reuters•2 days ago
Thermo Fisher raises 2019 forecasts, beats first quarter profit estimates
(Reuters) - Thermo Fisher Scientific Inc on Wednesday raised its 2019 forecasts for adjusted profit and revenue on the back of its $1.7 billion (£1.3 billion) deal to buy Brammer Bio, and beat the average ...
- Associated Press•2 days ago
Thermo Fisher: 1Q Earnings Snapshot
The Waltham, Massachusetts-based company said it had net income of $2.02 per share. Earnings, adjusted for one-time gains and costs, came to $2.81 per share. The results surpassed Wall Street expectations. ...
- Reuters•2 days ago
Thermo Fisher raises 2019 forecasts, beats Q1 profit estimates
Thermo Fisher Scientific Inc on Wednesday raised its 2019 forecasts for adjusted profit and revenue on the back of its $1.7 billion deal to buy Brammer Bio, and beat the average analyst estimate for first-quarter ...
- PR Newswire•2 days ago
Thermo Fisher Scientific Reports First Quarter 2019 Results
WALTHAM, Mass. , April 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, ...
- Investing.com•2 days ago
Thermo Fisher Scientific Earnings, Revenue Beat in Q1
Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported first quarter earnings that Beat analysts' expectations on Wednesday and revenue that topped forecasts.
- Zacks•3 days ago
What's in Store for Tandem Diabetes' (TNDM) Q1 Earnings?
The roll-out of Tandem Diabetes' (TNDM) unique insulin pump platform viz. t:slim X2 with Basal-IQ technology is expected to drive the top line in first-quarter 2019.
- Zacks•3 days ago
Why Earnings Season Could Be Great for Thermo Fisher (TMO)
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Motley Fool•6 days ago
Top Gene-Sequencing Stocks for 2019
These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
- Zacks•7 days ago
TMO or ABMD: Which Is the Better Value Stock Right Now?
TMO vs. ABMD: Which Stock Is the Better Value Option?
- Zacks•7 days ago
Thermo Fisher (TMO) to Report Q1 Earnings: What's in Store?
Strong analytical instruments business, product portfolio expansion and prudent growth strategy are likely to support Thermo Fisher (TMO) in Q1. However, forex might act as a dampener.
- Zacks•8 days ago
Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings?
We are optimistic about Boston Scientific's (BSX) IC business that will help maintain its impressive global growth trend in Q1 owing to an innovative portfolio and strong commercial teams.
- Zacks•9 days ago
Can Five Elements Drive Quest Diagnostics (DGX) Q1 Earnings?
Quest Diagnostics (DGX) seems in sync with its strategy to expedite growth and operational excellence.
- Zacks•9 days ago
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•10 days ago
Top Ranked Momentum Stocks to Buy for April 16th
Top Ranked Momentum Stocks to Buy for April 16th
- Zacks•10 days ago
Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?
Despite ongoing customers' transition from HiSeq consumables to NovaSeq, Illumina's (ILMN) Q1 results are expected to gain from this high throughput suite.
- Zacks•11 days ago
Can Medical Devices Strength Drive Abbott (ABT) Q1 Earnings?
Abbott (ABT) expects high single-digit growth in Medical Devices' sales in first-quarter 2019 and continued double-digit growth in certain sub-segments.
- Zacks•11 days ago
Will Abbott's (ABT) Steady Overall Growth Aid Q1 Earnings?
At the end of 2018, Abbott (ABT) posts some encouraging data, buoying investors' optimism on its Diabetes Care segment.
- Simply Wall St.•13 days ago
Thermo Fisher Scientific Inc. (NYSE:TMO): What We Can Expect From This Growth Stock
Since Thermo Fisher Scientific Inc. (NYSE:TMO) released its earnings in December 2018, analysts seem cautiously optimistic, with profits predicted to increase by 18% next year...
